According to a new study by Harvard researchers, the vast majority of yohimbe sold as a dietary supplement by mainstream retailers in the United States is mislabeled in a way that could pose a safety risk to consumers. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, is lead author of the study.
News & Research
